Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology.
- Author:
Mikio MIKAMI
1
;
Satoru NAGASE
;
Wataru YAMAGAMI
;
Kimio USHIJMA
;
Hironori TASHIRO
;
Hidetaka KATABUCHI
Author Information
- Publication Type:Randomized Controlled Trial ; Original Article
- Keywords: Ovarian Neoplasms; Salpingectomy; Prevention & Control
- MeSH: Accreditation; Endometrium; Endoscopy; Fallopian Tubes; Female; Gynecologic Surgical Procedures*; Gynecology*; Incidence; Japan*; Methods; Obstetrics*; Ovarian Neoplasms*; Postal Service; Salpingectomy*
- From:Journal of Gynecologic Oncology 2017;28(4):e52-
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention. METHODS: We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist. RESULTS: Among the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer. CONCLUSION: The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.
